PMDA Prioritizes Clinical Study Consultation On Oncology And Regenerative Medicine
This article was originally published in PharmAsia News
Executive Summary
Japan's Pharmaceutical and Medical Device Agency will focus a new clinical study consultation strategy on oncology, regenerative medicines, pediatric treatment and drugs for orphan and intractable diseases